These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23317923)

  • 1. Lafora disease: severe phenotype associated with homozygous deletion of the NHLRC1 gene.
    Kecmanović M; Jović N; Cukić M; Keckarević-Marković M; Keckarević D; Stevanović G; Romac S
    J Neurol Sci; 2013 Feb; 325(1-2):170-3. PubMed ID: 23317923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe and rapidly-progressive Lafora disease associated with NHLRC1 mutation: a case report.
    Casciato S; Gambardella S; Mascia A; Quarato PP; D'Aniello A; Ackurina Y; Albano V; Fornai F; Scala S; Di Gennaro G
    Int J Neurosci; 2017 Dec; 127(12):1150-1153. PubMed ID: 28556688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and genetic data on Lafora disease patients of Serbian/Montenegrin origin.
    Kecmanović M; Jović N; Keckarević-Marković M; Keckarević D; Stevanović G; Ignjatović P; Romac S
    Clin Genet; 2016 Jan; 89(1):104-8. PubMed ID: 25683376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lafora progressive myoclonus epilepsy: a meta-analysis of reported mutations in the first decade following the discovery of the EPM2A and NHLRC1 genes.
    Singh S; Ganesh S
    Hum Mutat; 2009 May; 30(5):715-23. PubMed ID: 19267391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mutations in EPM2A and NHLRC1 widen the spectrum of Lafora disease.
    Lesca G; Boutry-Kryza N; de Toffol B; Milh M; Steschenko D; Lemesle-Martin M; Maillard L; Foletti G; Rudolf G; Nielsen JE; á Rogvi-Hansen B; Erdal J; Mancini J; Thauvin-Robinet C; M'Rrabet A; Ville D; Szepetowski P; Raffo E; Hirsch E; Ryvlin P; Calender A; Genton P
    Epilepsia; 2010 Sep; 51(9):1691-8. PubMed ID: 20738377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three patients with lafora disease: different clinical presentations and a novel mutation.
    Poyrazoğlu HG; Karaca E; Per H; Gümüs H; Onay H; Canpolat M; Canöz Ö; Ozkınay F; Kumandas S
    J Child Neurol; 2015 May; 30(6):777-81. PubMed ID: 25015673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lafora disease in the Indian population: EPM2A and NHLRC1 gene mutations and their impact on subcellular localization of laforin and malin.
    Singh S; Satishchandra P; Shankar SK; Ganesh S
    Hum Mutat; 2008 Jun; 29(6):E1-12. PubMed ID: 18311786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the NHLRC1 gene are the common cause for Lafora disease in the Japanese population.
    Singh S; Suzuki T; Uchiyama A; Kumada S; Moriyama N; Hirose S; Takahashi Y; Sugie H; Mizoguchi K; Inoue Y; Kimura K; Sawaishi Y; Yamakawa K; Ganesh S
    J Hum Genet; 2005; 50(7):347-352. PubMed ID: 16021330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapidly progressive phenotype of Lafora disease associated with a novel NHLRC1 mutation.
    Brackmann FA; Kiefer A; Agaimy A; Gencik M; Trollmann R
    Pediatr Neurol; 2011 Jun; 44(6):475-7. PubMed ID: 21555062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic studies in patients with Lafora disease from Pakistan.
    Ahmad A; Dad R; Ullah MI; Baig TA; Ahmad IN; Nasir A; Hübner CA; Hassan MJ
    J Neurol Sci; 2017 Feb; 373():263-267. PubMed ID: 28131202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel NHLRC1 mutations and genotype-phenotype correlations in patients with Lafora's progressive myoclonic epilepsy.
    Singh S; Sethi I; Francheschetti S; Riggio C; Avanzini G; Yamakawa K; Delgado-Escueta AV; Ganesh S
    J Med Genet; 2006 Sep; 43(9):e48. PubMed ID: 16950819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four novel and two recurrent NHLRC1 (EPM2B) and EPM2A gene mutations leading to Lafora disease in six Turkish families.
    Salar S; Yeni N; Gündüz A; Güler A; Gökçay A; Velioğlu S; Gündoğdu A; Hande Çağlayan S
    Epilepsy Res; 2012 Feb; 98(2-3):273-6. PubMed ID: 22047982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rare rs769301934 variant in NHLRC1 is a common cause of Lafora disease in Turkey.
    Haryanyan G; Ozdemir O; Tutkavul K; Dervent A; Ayta S; Ozkara C; Salman B; Yucesan E; Kesim Y; Susgun S; Ozbek U; Baykan B; Ugur Iseri SA; Bebek N
    J Hum Genet; 2021 Dec; 66(12):1145-1151. PubMed ID: 34117373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presenting symptoms of Lafora Disease: An electroclinical and genetic study in five Apulian (Southern Italy) families.
    d'Orsi G; Lalla A; Palumbo O; Di Claudio MT; Valenzano A; Sabetta A; Lopopolo A; Muro ED; Palumbo P; Copetti M; Carella M; Avolio C
    Seizure; 2020 Dec; 83():145-153. PubMed ID: 33152654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound heterozygosity for novel variations of the NHLRC1 Gene in a family with Lafora disease.
    Tang X; Li X; Chen Y; Wu D
    Clin Neurol Neurosurg; 2022 Jul; 218():107255. PubMed ID: 35569391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The second family affected with a PRDM8-related disease.
    Davarzani A; Shahrokhi A; Hashemi SS; Ghasemi A; Habibi Kavashkohei MR; Farboodi N; Lang AE; Ghiasi M; Rohani M; Alavi A
    Neurol Sci; 2022 Jun; 43(6):3847-3855. PubMed ID: 35034233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild Lafora disease: clinical, neurophysiologic, and genetic findings.
    Ferlazzo E; Canafoglia L; Michelucci R; Gambardella A; Gennaro E; Pasini E; Riguzzi P; Plasmati R; Volpi L; Labate A; Gasparini S; Villani F; Casazza M; Viri M; Zara F; Minassian BA; Turnbull J; Serratosa JM; Guerrero-López R; Franceschetti S; Aguglia U
    Epilepsia; 2014 Dec; 55(12):e129-33. PubMed ID: 25270369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late onset Lafora disease and novel EPM2A mutations: breaking paradigms.
    Jara-Prado A; Ochoa A; Alonso ME; Lima Villeda GA; Fernández-Valverde F; Ruano-Calderón L; Vargas-Cañas S; Durón RM; Delgado-Escueta AV; Martínez-Juárez IE
    Epilepsy Res; 2014 Nov; 108(9):1501-10. PubMed ID: 25246353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic disease as the first manifestation of progressive myoclonus epilepsy of Lafora.
    Gómez-Garre P; Gutiérrez-Delicado E; Gómez-Abad C; Morales-Corraliza J; Villanueva VE; Rodríguez de Córdoba S; Larrauri J; Gutiérrez M; Berciano J; Serratosa JM
    Neurology; 2007 Apr; 68(17):1369-73. PubMed ID: 17452581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in NHLRC1 cause progressive myoclonus epilepsy.
    Chan EM; Young EJ; Ianzano L; Munteanu I; Zhao X; Christopoulos CC; Avanzini G; Elia M; Ackerley CA; Jovic NJ; Bohlega S; Andermann E; Rouleau GA; Delgado-Escueta AV; Minassian BA; Scherer SW
    Nat Genet; 2003 Oct; 35(2):125-7. PubMed ID: 12958597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.